Keratoconjunctivitis

MILAN — In this video perspective at the ESCRS meeting, Dominique Brémond-Gignac, MD, PhD, speaks about cyclosporine as a novel promising treatment for vernal keratoconjunctivitis.

In June 2021, Verkazia was approved for the treatment of vernal keratoconjunctivitis in children and adults.

WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Laura M. Periman, MD, discusses superior limbic keratoconjunctivitis and the potential use of neuromodulators to ease patients’ symptoms.

An 8-month follow-up extension of the Vernal Keratoconjunctivitis Study, or VEKTIS, showed that continuous use of cyclosporine is safe and effective for the treatment of vernal keratoconjunctivitis in children and adolescents.

While recent data have shown no increased risk for COVID-19 through contact lens wear and indicates that the use of contact lenses remains ultimately safe, researchers highlighted the need for altered management including advising patients to reduce or eliminate sleeping in contacts and using telehealth to discuss care.

The Institut National D’excellence en Santé et en Services Sociaux in Quebec has recommended the inclusion of Verkazia eye drops on the lists of drugs for the treatment of severe vernal keratoconjunctivitis, Santen Canada announced in a press release.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

The Canadian Drug Expert Committee has issued a reimbursement recommendation for Verkazia eye drops, a treatment for severe vernal keratoconjunctivitis, according to a press release.

A new 15 mL bottle of Neovis Total Multi, an artificial tear emulsion for dry eyes with keratitis or dry keratoconjunctivitis, has been launched in French, Belgium and Spain, Horus Pharma announced in a press release.